Screener
Pulse Biosciences, Inc. PLSE Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Pulse Biosciences, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026288
FAQ
- What is Pulse Biosciences, Inc.'s debt-to-equity?
- Pulse Biosciences, Inc. (PLSE) reported debt-to-equity of 0.1× in Q2 2026.
- How has Pulse Biosciences, Inc.'s debt-to-equity changed year-over-year?
- Pulse Biosciences, Inc.'s debt-to-equity decreased by 13.7% year-over-year, from 0.1× to 0.1×.
- What is the long-term trend for Pulse Biosciences, Inc.'s debt-to-equity?
- Over 4 years (2020 to 2025), Pulse Biosciences, Inc.'s debt-to-equity has grown at a -34.1% compound annual growth rate (CAGR), from 0.5× to 0.1×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Pulse Biosciences, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude